Skip to content

Clinical Study on Dabur Chyawanprash in Health & Immunity related Parameters in Healthy children

A Two Arm, Randomized, Open Labeled, Prospective, Clinical Study to Evaluate efficacy and safety of Dabur Chyawanprash in Health & Immunity related Parameters in Healthy children â?? A School Based Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/02/005574
Enrollment
720
Registered
2015-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Dabur Chyawanprash: Dabur Chyawanprash is a multiple ingredient ayurvedic formulation. Chyawanprash also helps to provide strength, stamina and energy. It has to be taken Half teaspoon

Sponsors

Dabur India Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Healthy children of either sex of 5-12 years (both inclusive) 2 Ready to provide informed consent from parent/ legally accepted guardian 3 No significant medical or surgical disease/s at the time of screening 4 No history of allergic conditions to Chyawanprash like products/any ingredients of the Chyawanprash and are not averse to consuming Chyawanprash for the study period 5 Willing to come for the follow up visits for evaluation

Exclusion criteria

Exclusion criteria: 1 Presence of any clinically significant medical or surgical condition requiring long term treatment 2 Subjects participating/participated in another clinical study within 3 months before recruitment 3 Evidence of significant uncontrolled concomitant disease which in the Investigators opinion would preclude patient participation 4 Immunologically compromised children

Design outcomes

Primary

MeasureTime frame
Assessment of immunity through episodes severity and duration of illness (infections or allergies) in the two study groups based on subject diaryTimepoint: 180 days (6 months)

Secondary

MeasureTime frame
Assessment will done in two study groups - immunity through no of children having infections or allergies, difference of absent days in school due to infections or allergies,no of children for absent days in school due to infections or allergies, change in energy levels, physical fitness, strength and stamina and no of children having change in energy levels, physical fitness, strength &stamina & change in quality of life & Physicians Global evaluation on CGI-I Scale and safety and tolerabilityTimepoint: 180 days (6 Months)

Countries

India

Contacts

Public ContactDr Sanjay Tamoli

Dabur India Limited

arun.gupta@dabur.com09910200255

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 27, 2026